文献速递消化道肿瘤与早癌消化内镜

结直肠肿瘤内镜黏膜下剥离术的临床结局:广岛消化内镜研究组的大规模多中心回顾性研究

Clinical outcomes of endoscopic submucosal dissection for colorectal tumors: a large multicenter retrospective study from the Hiroshima GI Endoscopy Research Group.
PubMed 文献 · Gastrointest Endosc · 2017-06-13

该多中心回顾性研究纳入12家机构(含非专科医院)的1233例患者共1259个结直肠肿瘤,评估内镜黏膜下剥离术的整块切除率、组织学完全切除率、治愈性(R0)切除率、不良事件及长期预后。结果显示整块切除率92.6%、组织学完全切除率87.4%、R0切除率83.7%,延迟出血3.7%、术中穿孔3.4%、延迟穿孔0.4%,局部复发1.7%,3年和5年总生存率分别为95.1%和92.3%。结论认为结直肠内镜黏膜下剥离术可行,不良事件风险可接受,长期预后良好。

要点

  • 整块切除率92.6%,组织学完全切除率87.4%,R0切除率83.7%。
  • 延迟出血3.7%,术中穿孔3.4%,延迟穿孔0.4%。
  • 局部复发1.7%,异时性肿瘤(>5 mm)发生率11.0%,5年总生存率92.3%。

核心结论

  • 结直肠内镜黏膜下剥离术可行,不良事件风险可接受,长期预后良好。

研究设计与样本

  • 多中心回顾性调查,纳入12家机构(含非专科医院)的1233例连续患者共1259个经内镜黏膜下剥离术切除的结直肠肿瘤。
  • 长期结局分析纳入1091例患者(88.4%)。
  • 临床试验注册号:UMIN000016197。

主要发现

  • 整块切除率92.6%,组织学完全切除率87.4%,R0切除率83.7%。
  • 延迟出血率3.7%,术中穿孔率3.4%,延迟穿孔率0.4%。
  • 局部复发率1.7%,异时性肿瘤(>5 mm)发生率11.0%。
  • 3年和5年总生存率分别为95.1%和92.3%。
  • 高容量中心(Group H)的结肠肿瘤数量、严重黏膜下纤维化和整块切除率显著高于低容量中心(Group L);Group H的平均肿瘤大小显著大于Group L。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Although advanced high-volume centers have reported good outcomes of colorectal endoscopic submucosal dissection (ESD), a limited number of highly skilled experts in specialized institutions performed these procedures. We undertook a retrospective multicenter survey, which included nonspecialized hospitals, to investigate the clinical outcomes of colorectal ESD. METHODS: We recruited 1233 consecutive patients with 1259 colorectal tumors resected by ESD at 12 institutions. We evaluated the en bloc resection rate, histologic complete resection rate, curative (R0) resection rate, adverse events, and the long-term prognoses, including local recurrence, metachronous tumor development, and survival rate. RESULTS: The en bloc, histologic complete, and R0 resection rates were 92.6%, 87.4%, and 83.7%, respectively. The delayed bleeding, intraoperative perforation, and delayed perforation rates were 3.7%, 3.4%, and .4%, respectively. The long-term outcomes analysis included 1091 patients (88.4%). Local recurrences occurred in 1.7%, and metachronous tumors (>5 mm) developed in 11.0% of the patients. The 3- and 5-year overall survival rates were 95.1% and 92.3%, respectively. The number of colonic tumors, severe submucosal fibrosis, and en bloc resection rates were significantly higher in the high-volume centers (Group H) than those in the low-volume centers (Group L). The average tumor size in Group H was significantly larger than that in Group L. CONCLUSIONS: Colorectal ESDs are feasible, have acceptable adverse event risks, and favorable long-term prognoses. (Clinical trial registration number: UMIN000016197.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Boda K, Oka S, Tanaka S, et al. Clinical outcomes of endoscopic submucosal dissection for colorectal tumors: a large multicenter retrospective study from the Hiroshima GI Endoscopy Research Group. Gastrointest Endosc. 2017. PMID: 28623057. doi:10.1016/j.gie.2017.05.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。